Global AI In Genomics
Market Report
2024
AI In Genomics Market Report 2024 (Global Edition)
AI In Genomics market will be USD 0.4 billion in 2024 and expand at a compound annual growth rate (CAGR) of 30.1% from 2024 to 2031.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of AI In Genomics Market Report 2024.
Global AI In Genomics Market Report 2024 Market Size Split by Component (Hardware, Software, Services), by Technology (Machine Learning, Computer Vision), by Functionality (Genome Sequencing, Gene Edi...
According to Cognitive Market Research, the global AI In Genomics market will be USD 0.4 billion in 2024 and expand at a compound annual growth rate (CAGR) of 30.1% from 2024 to 2031.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global AI In Genomics Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 30.1% |
| Market Split by Component |
|
| Market Split by Technology |
|
| Market Split by Functionality |
|
| Market Split by Application |
|
| Market Split by End Use |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of AI In Genomics industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
AI In Genomics Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
AI In Genomics Market Report Description
Introduction of AI In Genomics Market
Artificial intelligence (AI) and related technologies are increasingly being applied in a variety of industries and disciplines, including healthcare. AI is being used effectively in a variety of situations, including hospitals and clinical laboratories, as well as research methods. Along with increased use in engines, machines, and other applications, AI is used in electronic health records (EHR) and the growth of fields in life sciences and neurosciences. The most important aspect of AI in medicine is disease detection and treatment. The global artificial intelligence (AI) in the genomics market is expanding rapidly due to increasing biomedical and genomic datasets, increased acceptance of AI-based solutions, and a growing emphasis on reducing turnaround time in drug discovery and diagnostics. However, there is a shortage of educated workforce and infrastructure, ambiguous regulatory guidelines for genomics software, and poor security and storage of large amounts of genome sequencing data.
1716204042.webp "AI In Genomics Market Report 2024 (Global Edition)")
Market Dynamics of AI In Genomics Market
Key Drivers for AI In Genomics Market
Increasing Adoption of AI-Based Solutions - AI is also used to detect genetic alterations in tumors via 3D imaging. For example, a future technique could accurately detect glioma-type tumors that begin in the glial cells of the brain or spine using a patient's brain scans. Using deep learning and neural network technologies, the treatment procedure can be greatly improved, allowing doctors to avoid collecting tissue samples from a biopsy and eliminate the dangers associated with surgery. AI and ML offer several potentials for diagnosis automation. The digitization of health-related data, as well as the rapid adoption of technology, are promoting transformation and improvements in the development and implementation of artificial intelligence in healthcare. Increased biomedical and genomic datasets will drive market growth
Key Restraints for AI In Genomics Market
Lack of Skilled Workforce and Infrastructure Ambiguous Regulatory Guidelines for Genomics Software
We have various report editions of AI In Genomics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
AI In Genomics Market Insights Video
Competitive Landscape of the AI In Genomics Market
In October 2020, NVIDIA announced a collaboration with GSK, a major healthcare business, and its AI group, which uses computation in the medicine and vaccine discovery process. GSK recently built a new AI facility in London, one of the first of its type, which will use GSK's extensive genetic and genomic data to better the design and development of transformational medicines and vaccines.
Top Companies Market Share in AI In Genomics Industry: (In no particular order of Rank)
- IBM
- Microsoft Corporation
- NVIDIA Corporation
- DEEP GENOMICS
- Data4Cure Inc.
- Freenome Holdings Inc.
- Thermo Fisher Scientific
- Illumina Inc.
- SOPHiA GENETICS
- BenevolentAI
- Fabric Genomics
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Regional Analysis of AI In Genomics Market
Which Region will dominate the AI In the Genomics Market in 2024?
According to Cognitive Market Research, in 2024, North America held the bulk of the worldwide AI in genomics market share due to the presence of several market players, including Danone, Abbott, Nestlé, Targeted Medical Pharma, Inc., and Mead Johnson & Company, LLC, among others. North America is home to some of the world's largest and best-funded research institutes and biotechnology firms, and these organisations are making significant investments in the development of AI-powered genomics solutions. This is encouraging the development of new software and tools for genomic data processing, and it is helping to build the AI in genomics market in North America.
Which Region is Expanding at the Fastest CAGR?
Asia Pacific is predicted to have the fastest CAGR over the projection period. The region's demand for AI in genomics is being driven by a mix of fast-rising healthcare spending, a growing emphasis on precision medicine, breakthroughs in genomics technology, and a big and expanding population. Some Asian countries have launched national genomics programs, developing population genetic databases by sequencing the DNA of healthy individuals. In 2019, Thailand's government authorized a five-year Genomics Initiative worth USD 150 million to characterize the genomes of 50,000 inhabitants.
The current report Scope analyzes AI In Genomics Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
AI In Genomics Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
AI In Genomics Market Analysis
Global AI In Genomics Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing AI In Genomics Industry growth. AI In Genomics market has been segmented with the help of its Component, Technology Functionality, and others. AI In Genomics market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Component Segment Analysis of AI In Genomics Market
Based on present and future trends, the market size is estimated from 2019 to 2031. Moreover, study also provides quantitative and qualitative analysis of each type to understand the driving factors for the fastest growing type segment for AI In Genomics market.
Component of AI In Genomics analyzed in this report are as follows:
- Hardware
- Software
- Services
AI In Genomics Market Share (%) by Component in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of AI In Genomics Industry. Request a Free Sample PDF!
Technology Segment Analysis of AI In Genomics Market
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities for each application of AI In Genomics from 2019 to 2031. This will also help to analyze the demand for AI In Genomics across different end-use industries. Our research team will also help acquire additional data such as Value Chain, Patent analysis, Company Evaluation Quadrant (Matrix), and much more confidential analysis and data insights.
Some of the key Technology of AI In Genomics are:
- Machine Learning
- Computer Vision
AI In Genomics Market Share (%) by Technology in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
AI In Genomics Functionality Segment Analysis
- Genome Sequencing
- Gene Editing
- Others
AI In Genomics Application Segment Analysis
- Drug Discovery & Development
- Precision Medicine
- Diagnostics
- Others
AI In Genomics End Use Segment Analysis
According to Cognitive Market Research, Pharmaceutical and biotech companies dominated the market in 2024. Artificial intelligence and machine learning are widely employed in the biotech and pharmaceutical industries for applications such as clinical data management, automated disease prediction and prevention, and biomarker identification. Artificial intelligence algorithms can forecast the toxicity of potential treatments, allowing pharmaceutical corporations to avoid investing in drugs that are likely to fail in clinical trials.
- Pharmaceutical and Biotech Companies
- Healthcare Providers
- Research Centers
- Others
Author's Detail
Manjiri KanhereSenior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global AI In Genomics Market is witnessing significant growth in the near future.
In 2023, the Hardware segment accounted for noticeable share of global AI In Genomics Market and is projected to experience significant growth in the near future.
The Machine Learning segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies IBM , NVIDIA Corporation and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about AI In Genomics Market
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://en.wikipedia.org/wiki/Healthcare_industry
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- http://: https://www.who.int/tools/atc-ddd-toolkit/data
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
AI In Genomics Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Component | Hardware, Software, Services |
| Technology | Machine Learning, Computer Vision |
| Functionality | Genome Sequencing, Gene Editing, Others |
| Application | Drug Discovery & Development, Precision Medicine, Diagnostics, Others |
| End Use | Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers, Others |
| List of Competitors | IBM, Microsoft Corporation, NVIDIA Corporation, DEEP GENOMICS, Data4Cure Inc., Freenome Holdings Inc., Thermo Fisher Scientific, Illumina Inc., SOPHiA GENETICS, BenevolentAI, Fabric Genomics |
This chapter will help you gain GLOBAL Market Analysis of AI In Genomics. Further deep in this chapter, you will be able to review Global AI In Genomics Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global AI In Genomics Market Size, Trend Analysis 2019 - 2031
-
1.2 Global AI In Genomics Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global AI In Genomics Revenue Market Size By Region
-
-
1.3 Global AI In Genomics Market Size By Component 2019 -2031
-
1.3.1 Hardware Market Size
-
1.3.2 Software Market Size
-
1.3.3 Services Market Size
-
-
1.4 Global AI In Genomics Market Size By Technology 2019 -2031
-
1.4.1 Machine Learning Market Size
-
1.4.2 Computer Vision Market Size
-
-
1.5 Global AI In Genomics Market Size By Functionality 2019 -2031
-
1.5.1 Genome Sequencing Market Size
-
1.5.2 Gene Editing Market Size
-
1.5.3 Others Market Size
-
-
1.6 Global AI In Genomics Market Size By Application for 2019 -2031
-
1.6.1 Drug Discovery & Development Market Size
-
1.6.2 Precision Medicine Market Size
-
1.6.3 Diagnostics Market Size
-
1.6.4 Others Market Size
-
-
1.7 Global AI In Genomics Market Size By End Use for 2019 -2031
-
1.7.1 Pharmaceutical and Biotech Companies Market Size
-
1.7.2 Healthcare Providers Market Size
-
1.7.3 Research Centers Market Size
-
1.7.4 Others Market Size
-
-
1.8 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.9 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.9.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.9.2 Global Market Revenue Split By Component
-
1.9.3 Global Market Revenue Split By Technology
-
1.9.4 Global Market Revenue Split By Functionality
-
1.9.5 Global Market Revenue Split By Application
-
1.9.6 Global Market Revenue Split By End Use
-
1.9.7 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America AI In Genomics Market Size 2019 - 2031
-
2.1.1 North America AI In Genomics Market Size By Country 2019 - 2031
-
2.1.2 North America AI In Genomics Market Size by Component 2019 -2031
-
2.1.2.1 North America Hardware Market Size
-
2.1.2.2 North America Software Market Size
-
2.1.2.3 North America Services Market Size
-
-
2.1.3 North America AI In Genomics Market Size by Technology 2019 -2031
-
2.1.3.1 North America Machine Learning Market Size
-
2.1.3.2 North America Computer Vision Market Size
-
-
2.1.4 North America AI In Genomics Market Size by Functionality 2019 -2031
-
2.1.4.1 North America Genome Sequencing Market Size
-
2.1.4.2 North America Gene Editing Market Size
-
2.1.4.3 North America Others Market Size
-
-
2.1.5 North America AI In Genomics Market Size by Application 2019 -2031
-
2.1.5.1 North America Drug Discovery & Development Market Size
-
2.1.5.2 North America Precision Medicine Market Size
-
2.1.5.3 North America Diagnostics Market Size
-
2.1.5.4 North America Others Market Size
-
-
2.1.6 North America AI In Genomics Market Size by End Use 2019 -2031
-
2.1.6.1 North America Pharmaceutical and Biotech Companies Market Size
-
2.1.6.2 North America Healthcare Providers Market Size
-
2.1.6.3 North America Research Centers Market Size
-
2.1.6.4 North America Others Market Size
-
-
Chapter 3 Europe Market Analysis
-
3.1 Europe AI In Genomics Market Size 2019 - 2031
-
3.1.1 Europe AI In Genomics Market Size By Country 2019 - 2031
-
3.1.2 Europe AI In Genomics Market Size by Component 2019 -2031
-
3.1.2.1 Europe Hardware Market Size
-
3.1.2.2 Europe Software Market Size
-
3.1.2.3 Europe Services Market Size
-
-
3.1.3 Europe AI In Genomics Market Size by Technology 2019 -2031
-
3.1.3.1 Europe Machine Learning Market Size
-
3.1.3.2 Europe Computer Vision Market Size
-
-
3.1.4 Europe AI In Genomics Market Size by Functionality 2019 -2031
-
3.1.4.1 Europe Genome Sequencing Market Size
-
3.1.4.2 Europe Gene Editing Market Size
-
3.1.4.3 Europe Others Market Size
-
-
3.1.5 Europe AI In Genomics Market Size by Application 2019 -2031
-
3.1.5.1 Europe Drug Discovery & Development Market Size
-
3.1.5.2 Europe Precision Medicine Market Size
-
3.1.5.3 Europe Diagnostics Market Size
-
3.1.5.4 Europe Others Market Size
-
-
3.1.6 Europe AI In Genomics Market Size by End Use 2019 -2031
-
3.1.6.1 Europe Pharmaceutical and Biotech Companies Market Size
-
3.1.6.2 Europe Healthcare Providers Market Size
-
3.1.6.3 Europe Research Centers Market Size
-
3.1.6.4 Europe Others Market Size
-
-
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific AI In Genomics Market Size 2019 - 2031
-
4.1.1 Asia Pacific AI In Genomics Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific AI In Genomics Market Size by Component 2019 -2031
-
4.1.2.1 Asia Pacific Hardware Market Size
-
4.1.2.2 Asia Pacific Software Market Size
-
4.1.2.3 Asia Pacific Services Market Size
-
-
4.1.3 Asia Pacific AI In Genomics Market Size by Technology 2019 -2031
-
4.1.3.1 Asia Pacific Machine Learning Market Size
-
4.1.3.2 Asia Pacific Computer Vision Market Size
-
-
4.1.4 Asia Pacific AI In Genomics Market Size by Functionality 2019 -2031
-
4.1.4.1 Asia Pacific Genome Sequencing Market Size
-
4.1.4.2 Asia Pacific Gene Editing Market Size
-
4.1.4.3 Asia Pacific Others Market Size
-
-
4.1.5 Asia Pacific AI In Genomics Market Size by Application 2019 -2031
-
4.1.5.1 Asia Pacific Drug Discovery & Development Market Size
-
4.1.5.2 Asia Pacific Precision Medicine Market Size
-
4.1.5.3 Asia Pacific Diagnostics Market Size
-
4.1.5.4 Asia Pacific Others Market Size
-
-
4.1.6 Asia Pacific AI In Genomics Market Size by End Use 2019 -2031
-
4.1.6.1 Asia Pacific Pharmaceutical and Biotech Companies Market Size
-
4.1.6.2 Asia Pacific Healthcare Providers Market Size
-
4.1.6.3 Asia Pacific Research Centers Market Size
-
4.1.6.4 Asia Pacific Others Market Size
-
-
Chapter 5 South America Market Analysis
-
5.1 South America AI In Genomics Market Size 2019 - 2031
-
5.1.1 South America AI In Genomics Market Size By Country 2019 - 2031
-
5.1.2 South America AI In Genomics Market Size by Component 2019 -2031
-
5.1.2.1 South America Hardware Market Size
-
5.1.2.2 South America Software Market Size
-
5.1.2.3 South America Services Market Size
-
-
5.1.3 South America AI In Genomics Market Size by Technology 2019 -2031
-
5.1.3.1 South America Machine Learning Market Size
-
5.1.3.2 South America Computer Vision Market Size
-
-
5.1.4 South America AI In Genomics Market Size by Functionality 2019 -2031
-
5.1.4.1 South America Genome Sequencing Market Size
-
5.1.4.2 South America Gene Editing Market Size
-
5.1.4.3 South America Others Market Size
-
-
5.1.5 South America AI In Genomics Market Size by Application 2019 -2031
-
5.1.5.1 South America Drug Discovery & Development Market Size
-
5.1.5.2 South America Precision Medicine Market Size
-
5.1.5.3 South America Diagnostics Market Size
-
5.1.5.4 South America Others Market Size
-
-
5.1.6 South America AI In Genomics Market Size by End Use 2019 -2031
-
5.1.6.1 South America Pharmaceutical and Biotech Companies Market Size
-
5.1.6.2 South America Healthcare Providers Market Size
-
5.1.6.3 South America Research Centers Market Size
-
5.1.6.4 South America Others Market Size
-
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa AI In Genomics Market Size 2019 - 2031
-
6.1.1 Middle East and Africa AI In Genomics Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa AI In Genomics Market Size by Component 2019 -2031
-
6.1.2.1 Middle East and Africa Hardware Market Size
-
6.1.2.2 Middle East and Africa Software Market Size
-
6.1.2.3 Middle East and Africa Services Market Size
-
-
6.1.3 Middle East and Africa AI In Genomics Market Size by Technology 2019 -2031
-
6.1.3.1 Middle East and Africa Machine Learning Market Size
-
6.1.3.2 Middle East and Africa Computer Vision Market Size
-
-
6.1.4 Middle East and Africa AI In Genomics Market Size by Functionality 2019 -2031
-
6.1.4.1 Middle East and Africa Genome Sequencing Market Size
-
6.1.4.2 Middle East and Africa Gene Editing Market Size
-
6.1.4.3 Middle East and Africa Others Market Size
-
-
6.1.5 Middle East and Africa AI In Genomics Market Size by Application 2019 -2031
-
6.1.5.1 Middle East and Africa Drug Discovery & Development Market Size
-
6.1.5.2 Middle East and Africa Precision Medicine Market Size
-
6.1.5.3 Middle East and Africa Diagnostics Market Size
-
6.1.5.4 Middle East and Africa Others Market Size
-
-
6.1.6 Middle East and Africa AI In Genomics Market Size by End Use 2019 -2031
-
6.1.6.1 Middle East and Africa Pharmaceutical and Biotech Companies Market Size
-
6.1.6.2 Middle East and Africa Healthcare Providers Market Size
-
6.1.6.3 Middle East and Africa Research Centers Market Size
-
6.1.6.4 Middle East and Africa Others Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1AI In Genomics Market Size by Component 2019 -2031
-
7.1.2 Country 1AI In Genomics Market Size by Technology 2019 -2031
-
7.1.3 Country 1AI In Genomics Market Size by Functionality 2019 -2031
-
7.1.4 Country 1AI In Genomics Market Size by Application 2019 -2031
-
7.1.5 Country 1AI In Genomics Market Size by End Use 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global AI In Genomics Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 IBM
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Microsoft Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 NVIDIA Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 DEEP GENOMICS
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Data4Cure Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Freenome Holdings Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Thermo Fisher Scientific
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Illumina Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 SOPHiA GENETICS
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 BenevolentAI
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 Fabric Genomics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Component Analysis 2019 -2031, will provide market size split by Component. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Component Analysis 2019 -2031
-
10.1 Hardware
-
10.1.1 Global AI In Genomics Revenue Market Size and Share by Hardware 2019 -2031
-
-
10.2 Software
-
10.2.1 Global AI In Genomics Revenue Market Size and Share by Software 2019 -2031
-
-
10.3 Services
-
10.3.1 Global AI In Genomics Revenue Market Size and Share by Services 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Technology Analysis 2019 -2031
-
11.1 Machine Learning
-
11.1.1 Global AI In Genomics Revenue Market Size and Share by Machine Learning 2019 - 2031
-
-
11.2 Computer Vision
-
11.2.1 Global AI In Genomics Revenue Market Size and Share by Computer Vision 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Functionality Analysis 2019 -2031
-
12.1 Genome Sequencing
-
12.1.1 Global AI In Genomics Revenue Market Size and Share by Genome Sequencing 2019 -2031
-
-
12.2 Gene Editing
-
12.2.1 Global AI In Genomics Revenue Market Size and Share by Gene Editing 2019 -2031
-
-
12.3 Others
-
12.3.1 Global AI In Genomics Revenue Market Size and Share by Others 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Application Analysis 2019 -2031
-
13.1 Drug Discovery & Development
-
13.1.1 Global AI In Genomics Revenue Market Size and Share by Drug Discovery & Development 2019 -2031
-
-
13.2 Precision Medicine
-
13.2.1 Global AI In Genomics Revenue Market Size and Share by Precision Medicine 2019 -2031
-
-
13.3 Diagnostics
-
13.3.1 Global AI In Genomics Revenue Market Size and Share by Diagnostics 2019 -2031
-
-
13.4 Others
-
13.4.1 Global AI In Genomics Revenue Market Size and Share by Others 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by End Use Analysis 2019 -2031
-
14.1 Pharmaceutical and Biotech Companies
-
14.1.1 Global AI In Genomics Revenue Market Size and Share by Pharmaceutical and Biotech Companies 2019 -2031
-
-
14.2 Healthcare Providers
-
14.2.1 Global AI In Genomics Revenue Market Size and Share by Healthcare Providers 2019 -2031
-
-
14.3 Research Centers
-
14.3.1 Global AI In Genomics Revenue Market Size and Share by Research Centers 2019 -2031
-
-
14.4 Others
-
14.4.1 Global AI In Genomics Revenue Market Size and Share by Others 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global AI In Genomics market
Chapter 15 Research Findings
-
15.1 Key Takeaways
-
15.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
15.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Manjiri Kanhere and Team
- 1.1 AI In Genomics Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for AI In Genomics Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for AI In Genomics Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for AI In Genomics Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for AI In Genomics Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for AI In Genomics Market
Key Questions Answered By AI In Genomics Market Report 2024
| Why Hardware have a significant impact on AI In Genomics market? |
| What are the key factors affecting the Hardware and Software of AI In Genomics Market? |
| What is the CAGR/Growth Rate of Machine Learning during the forecast period? |
| By type, which segment accounted for largest share of the global AI In Genomics Market? |
| Which region is expected to dominate the global AI In Genomics Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
